Clinical Trial: Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
Study Status: Completed
Recruit Status: Completed
Condition: Drug Use
Study Type: Interventional
Official Title: Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
Brief Summary:
The study was conducted toinvestigate whether the bioavailability of 3 mg Glimepiride Tablet Manufactured by PT. Harsen Laboratories was bioequivalent to the reference product, 3 mg Amaryl® Tablet Manufactured by PT. Aventis Indonesia Pharma, Indonesia.
Read more